Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,189,609
+$7,490 QoQ
Shares Held
12,559
-3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#1,962
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCNB CORP holds $15,058,607 across 8 Drug Manufacturers - General names. JNJ ranks #2 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
26,283 | $3,377,365 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,559 | $3,189,609 | |
| 3 | AMGN |
Amgen Inc
|
6,635 | $2,402,666 | |
| 4 | LLY |
ELI LILLY & Co
|
1,804 | $2,163,771 | |
| 5 | ABBV |
AbbVie Inc.
|
7,943 | $1,998,776 | |
| 6 | NVS |
Novartis AG
|
8,673 | $1,359,232 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,990 | $287,523 | |
| 8 | PFE |
Pfizer Inc
|
11,614 | $279,665 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,189,609 | 12,559 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,182,119 | 13,018 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,710,838 | 13,099 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,379,865 | 12,835 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,991,249 | 13,036 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,187,097 | 13,188 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,006,602 | 13,875 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,263,167 | 13,965 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,108,211 | 14,424 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,363,042 | 14,938 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,328,215 | 14,854 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,278,778 | 14,631 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,702,445 | 16,327 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,526,345 | 16,299 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,911,192 | 16,480 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,793,456 | 17,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,170,328 | 17,860 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,223,104 | 18,186 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,934,021 | 17,151 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,701,895 | 16,730 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,689,380 | 16,325 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,573,721 | 15,660 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,591,261 | 16,465 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,439,398 | 16,385 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,344,723 | 16,673 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,218,981 | 16,922 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||